Molecular Partners AG Sponsored ADR (MOLN) vs PDS Biotechnology Corporation (PDSB)

Molecular Partners AG Sponsored ADR and PDS Biotechnology Corporation are both Biotechnology companies. Molecular Partners AG Sponsored ADR and PDS Biotechnology Corporation are of similar size ($129.2M and $119.2M). Across the 8 metrics below, PDS Biotechnology Corporation leads on 5 and Molecular Partners AG Sponsored ADR on 3.

Valuation

Metric MOLN PDSB Biotechnology median
P/E n/m n/m 10.60
P/S 21.86 n/m 9.40
P/B 1.98 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.32 n/m 9.02
Earnings yield (52.05%) (52.03%) (32.88%)
Free cash flow yield (45.19%) (24.15%) (23.13%)

Profitability

Metric MOLN PDSB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (71.08%) (543.97%) (51.96%)
Return on assets (58.83%) (136.65%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MOLN PDSB Biotechnology median
Revenue growth (TTM) (27.99%) — 6.76%
EPS growth (last fiscal year) (9.94%) 28.16% 29.88%
Revenue growth, 5-year CAGR (23.12%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MOLN PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 6.46 0.57 4.97
Net debt to EBITDA 1.66 0.50 1.01

Dividend

Metric MOLN PDSB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MOLN PDSB Biotechnology median
Market cap 119.24m 129.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack